Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

TRUVADA™ tablets 245mg+200mg, 30pcs

🔥 5 items sold in last 3 hours
23 people are viewing this product
Brand:
Active Ingredient:

,

Manufacturer:

$856.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

L-THYROXINE BERLIN CHEMIE™ tablets 100mcg, 100pcs

$10.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$8.00
Add to cart

Analogs of TRUVADA™

BIKTARVY™ tablets 50mg+25mg+200mg, 30pcs

$1,050.00
Add to cart

TENOF™ 300 tablets 300mg, 30pcs

$24.00
Add to cart

TENOFOVIR™-TL tablets 300mg, 30pcs

$30.00
Add to cart

Table of Contents

TRUVADA™ 245mg+200mg Tablets Buy Online

Understanding Truvada Tablets

What is Truvada?

Truvada is a combination antiretroviral medication used to treat HIV-1 infection in adults and adolescents. It contains two key components: emtricitabine and tenofovir disoproxil fumarate, working synergistically to combat the virus.

Truvada’s active ingredients interfere with the HIV replication process. Emtricitabine and tenofovir disoproxil fumarate inhibit reverse transcriptase, an enzyme crucial for HIV to reproduce. By blocking this enzyme, Truvada significantly reduces the viral load in the body.

As part of a comprehensive antiretroviral therapy (ART) regimen, Truvada helps manage HIV infection. It’s vital to remember that Truvada is not a cure but a crucial tool in managing the virus and improving the quality of life for individuals with HIV.

Truvada for PrEP (Pre-Exposure Prophylaxis)

Truvada is also approved for pre-exposure prophylaxis (PrEP), which helps prevent HIV infection in at-risk individuals. When taken consistently as prescribed, PrEP significantly reduces the risk of acquiring HIV through sexual contact or intravenous drug use.

What is Truvada?

Truvada, a crucial medication in the fight against HIV, is a fixed-dose combination tablet containing two powerful antiviral agents: emtricitabine and tenofovir disoproxil fumarate. This strategic pairing allows for a streamlined approach to managing the virus, simplifying treatment adherence for patients. Each tablet delivers a precise 245mg dose of tenofovir disoproxil fumarate and 200mg of emtricitabine, working together to effectively suppress HIV replication. The precise formulation ensures consistent and reliable delivery of both medications, optimizing therapeutic efficacy.

Its primary function is to inhibit the activity of reverse transcriptase, a vital enzyme HIV relies on to replicate itself within the body’s cells. By effectively blocking this enzyme, Truvada significantly reduces the viral load, easing the burden on the immune system. This reduction in viral replication is a cornerstone of effective HIV management, helping individuals maintain healthier immune function and improve their overall quality of life. Importantly, Truvada is used as part of a broader antiretroviral therapy (ART) regimen, and not as a standalone cure for HIV.

Beyond its role in treating HIV infection, Truvada is also utilized for pre-exposure prophylaxis (PrEP), a preventative measure for individuals at high risk of HIV acquisition. In this context, Truvada acts as a protective barrier, significantly reducing the likelihood of contracting HIV through sexual contact or needle sharing. This preventative application of Truvada underscores its versatility and significance in public health efforts to combat the spread of HIV. Regular and consistent use, as prescribed by a healthcare professional, is paramount for both therapeutic and prophylactic efficacy.

How Truvada Works

Truvada’s mechanism of action hinges on the synergistic effects of its two key components: emtricitabine and tenofovir disoproxil fumarate. Both are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), meaning they target reverse transcriptase, a crucial enzyme for HIV replication. This enzyme is vital for the virus because it converts its RNA genetic material into DNA, which then integrates into the host cell’s genome, allowing the virus to reproduce. By cleverly mimicking the natural building blocks of DNA, emtricitabine and tenofovir effectively halt this conversion process.

Emtricitabine, a nucleoside analog, competitively inhibits reverse transcriptase by incorporating itself into the growing DNA chain, thereby terminating its elongation and preventing further viral replication. Tenofovir, a nucleotide analog, operates similarly but is already a nucleotide, meaning it’s one step closer to the actual DNA building block, making its incorporation even more effective. This dual-pronged approach ensures a robust inhibition of reverse transcriptase, significantly reducing the amount of HIV in the bloodstream. The combined action of these two drugs ensures a powerful antiviral effect, contributing to a lower viral load and improved immune function in patients.

The precise dosages of 200mg emtricitabine and 245mg tenofovir disoproxil fumarate in each Truvada tablet are carefully calibrated to optimize their combined antiviral effect. This balanced formulation ensures that sufficient amounts of both drugs reach their target sites, maximizing their effectiveness. The result is a substantial reduction in HIV replication, leading to improved clinical outcomes for individuals with HIV infection, as well as providing significant protection against HIV acquisition for those undergoing PrEP. This dual-inhibition strategy forms the basis of Truvada’s effectiveness in managing and preventing HIV infection.

Truvada for HIV Treatment

Truvada plays a vital role in the comprehensive management of HIV-1 infection, but it’s crucial to understand that it’s not a cure. Instead, it’s a cornerstone of effective antiretroviral therapy (ART), working in conjunction with other medications to suppress the virus and improve the patient’s health. Its efficacy stems from its ability to significantly reduce the viral load, meaning the amount of HIV in the bloodstream. This reduction alleviates the pressure on the immune system, allowing it to function more effectively and reducing the risk of opportunistic infections.

When incorporated into a well-designed ART regimen, Truvada helps to improve CD4 cell counts, a key indicator of immune system health. Higher CD4 counts signify a stronger immune response, enabling the body to better defend itself against infections. The combination of emtricitabine and tenofovir disoproxil fumarate in Truvada provides a powerful, dual-action approach to suppressing HIV replication, leading to sustained viral suppression and improved clinical outcomes. Regular monitoring of viral load and CD4 counts is essential while on Truvada, ensuring the treatment remains effective.

The success of Truvada in HIV treatment relies heavily on adherence to the prescribed regimen. Consistent daily use is crucial to maintain effective viral suppression. Missing doses can lead to treatment failure, allowing the virus to rebound and potentially develop resistance to the medication. Therefore, patient education and support are essential components of successful HIV treatment with Truvada, ensuring both adherence to the prescribed dosage and regular monitoring of treatment effectiveness. Close collaboration with healthcare providers is vital for optimal results and to address any potential side effects or complications.

Truvada for PrEP (Pre-Exposure Prophylaxis)

Truvada’s role extends beyond treating existing HIV infections; it’s also a highly effective tool for pre-exposure prophylaxis (PrEP), a preventative strategy for individuals at substantial risk of acquiring HIV. PrEP involves taking Truvada daily to significantly reduce the chances of contracting HIV through sexual contact or intravenous drug use. This preventative approach is a powerful weapon in the fight against HIV, offering a crucial layer of protection for those who are at high risk but not yet infected.

The effectiveness of Truvada for PrEP is remarkable, demonstrating a substantial reduction in HIV transmission rates among at-risk populations. Studies have shown that consistent daily use of Truvada as PrEP can reduce the risk of HIV acquisition by over 90%. However, it’s vital to emphasize that PrEP is most effective when taken consistently, as prescribed, and in combination with other safer sex practices like using condoms. This multi-faceted approach maximizes protection and minimizes the risk of HIV transmission.

It’s important to note that Truvada for PrEP is not a substitute for safer sex practices. PrEP should be viewed as an additional layer of protection, not a replacement for responsible sexual behavior. Regular HIV testing is also crucial, even while on PrEP, to ensure that the medication remains effective and to detect any potential infection early. Access to comprehensive sexual health education and counseling is essential for individuals considering PrEP to fully understand its benefits, limitations, and the importance of consistent use and adherence to the recommended regimen. PrEP, when used correctly, represents a significant advancement in HIV prevention.

Important Considerations

Before starting Truvada, a thorough discussion with your healthcare provider is essential. Understanding potential side effects and drug interactions is crucial for safe and effective treatment. Regular monitoring of your health is necessary to ensure the medication is working as intended and to address any potential issues promptly. Always follow your doctor’s instructions precisely for optimal results.

Dosage and Administration

Truvada’s dosage and administration are crucial for its effectiveness. The standard dose is one tablet taken orally, once daily. Consistency is key; missing doses can significantly reduce the medication’s effectiveness and increase the risk of viral resistance. It’s vital to take Truvada exactly as prescribed by your healthcare provider; they will tailor the dosage and frequency to your specific needs and health status. Never adjust the dosage without consulting your doctor.

The timing of Truvada administration can be flexible; it can be taken with or without food. However, maintaining a consistent daily schedule is more important than the specific time of day. This consistency ensures that therapeutic levels of emtricitabine and tenofovir disoproxil fumarate are maintained in your bloodstream, maximizing the medication’s antiviral effects. If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose. Never double up on doses to compensate for a missed one.

For individuals using Truvada for PrEP, the recommended dosage remains one tablet daily. However, adherence is even more critical for PrEP, as consistent daily use is necessary to maintain a protective level of the medication in the body. Your healthcare provider will provide detailed instructions and guidance on proper administration and adherence strategies to ensure optimal protection against HIV acquisition. Regular follow-up appointments are essential to monitor adherence and assess the effectiveness of PrEP. Open communication with your doctor is critical to address any questions or concerns.

Side Effects

While Truvada offers significant benefits in managing and preventing HIV, it’s important to be aware of potential side effects. These can vary in severity and frequency among individuals. Common side effects often include nausea, diarrhea, vomiting, and abdominal pain. These gastrointestinal issues are usually mild and often subside as the body adjusts to the medication. However, if these symptoms persist or worsen, it’s crucial to consult your healthcare provider immediately.

Some individuals may experience more serious side effects, although these are less common. These can include kidney problems, indicated by changes in urine output or blood tests, and bone mineral density loss. Regular monitoring of kidney function and bone health is recommended, particularly for individuals with pre-existing kidney conditions or risk factors for bone loss. Your doctor will conduct regular check-ups and blood tests to monitor these aspects of your health and make necessary adjustments to your treatment plan if needed.

Less frequent but potentially serious side effects include lactic acidosis, a buildup of lactic acid in the blood, and severe allergic reactions. Lactic acidosis is characterized by symptoms such as fatigue, weakness, and abdominal pain. Severe allergic reactions can manifest as skin rashes, swelling, or difficulty breathing. These conditions necessitate immediate medical attention. Open communication with your healthcare provider is paramount to promptly address any side effects, ensuring both your safety and the efficacy of your treatment. Early detection and intervention are key to managing any potential complications.

Pros

Truvada offers several significant advantages in both the treatment and prevention of HIV. For those with HIV, Truvada, as part of an ART regimen, demonstrably reduces viral load, leading to improved immune function and a better quality of life. This translates to a reduced risk of opportunistic infections and improved overall health outcomes. The medication’s effectiveness in suppressing viral replication is well-documented, offering a significant improvement in the prognosis for individuals living with HIV.

The convenience of a once-daily dosage significantly improves adherence compared to more complex treatment regimens. This single-tablet approach simplifies treatment, making it easier for patients to maintain consistent medication intake. Improved adherence directly translates to better viral suppression and fewer opportunities for drug resistance to develop. This ease of use is a substantial advantage, enhancing the overall effectiveness of the treatment. The simplification reduces the cognitive burden on patients, improving the likelihood of long-term success.

For individuals utilizing Truvada for PrEP, the benefits are equally substantial. The high efficacy in preventing HIV acquisition offers a powerful preventative tool for those at high risk. This preventative aspect is a crucial element in public health strategies to combat the spread of HIV. Coupled with safer sex practices, PrEP significantly reduces the probability of contracting HIV, offering peace of mind and enhanced protection. The significant reduction in HIV transmission risk is a major public health achievement.

Cons

While Truvada offers substantial benefits, potential drawbacks warrant consideration. Gastrointestinal side effects such as nausea, diarrhea, and vomiting are relatively common, although usually mild and transient. These side effects often lessen as the body adjusts to the medication, but if they persist or are severe, medical advice should be sought. For some individuals, these gastrointestinal issues can significantly impact their daily lives, reducing their tolerance of the medication.

More serious, though less frequent, side effects include renal impairment and bone mineral density loss. Kidney problems, potentially indicated by changes in urine output or abnormal blood test results, may necessitate dose adjustments or alternative treatment options. Bone loss, a risk factor for osteoporosis and fractures, requires careful monitoring and may necessitate supplementary therapies to mitigate this adverse effect. Regular monitoring of kidney function and bone density is essential throughout treatment.

Truvada’s efficacy depends heavily on consistent daily adherence. Missing doses can compromise its effectiveness, potentially leading to treatment failure or the development of drug resistance. This necessitates a high degree of commitment and discipline from patients. For individuals struggling with adherence, support and counseling services may be beneficial in maintaining consistent medication intake and maximizing the treatment’s positive outcomes. The need for consistent adherence is a significant challenge for some patients.

Precautions

Before starting Truvada, it’s crucial to inform your healthcare provider about your complete medical history, including any pre-existing conditions, particularly kidney disease or bone disorders. Individuals with a history of liver disease should also discuss this with their doctor, as Truvada may affect liver function. Providing a comprehensive medical history allows your healthcare provider to assess potential risks and adjust the treatment plan accordingly, ensuring your safety and the effectiveness of the medication. Open communication about your health is paramount.

Women of childbearing age should discuss the use of effective contraception with their doctor while taking Truvada. The medication can potentially affect the efficacy of some birth control methods. It’s essential to employ reliable contraception during treatment to prevent unintended pregnancy. Regular check-ups and discussions with your healthcare provider are vital to monitor your health and address any concerns related to contraception or other aspects of your well-being.

Regular monitoring of kidney function and bone mineral density is recommended for all patients taking Truvada, especially those with risk factors for kidney disease or bone loss. This involves regular blood tests and potentially bone density scans to track any changes and make necessary adjustments to the treatment strategy. Proactive monitoring is crucial for early detection of potential problems, enabling timely intervention and minimizing potential complications. This preventative approach helps to ensure the long-term safety and efficacy of Truvada treatment.

  • Truvada™ Tablets 245Mg+200Mg, 30Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Truvada™ Tablets 245Mg+200Mg, 30Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Truvada™ Tablets 245Mg+200Mg, 30Pcs Buy Online 6
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “TRUVADA™ tablets 245mg+200mg, 30pcs”

Your email address will not be published. Required fields are marked

Similar products

LYNPARZA™ tablets 150mg, 56pcs

$10,650.00
Add to cart

XTANDI™ capsules 40mg, 112pcs

$11,062.00
Add to cart

CLADRIBINE concentrate for infusion solution 1mg/ml (10ml), vial 1pc

$299.00
Add to cart

CARBOPLATIN-RONC™ concentrate for infusion solution 10mg/ml (15ml), vial 1pc

$80.00
Add to cart

CABOMETYX™ tablets 20mg, 30pcs

$25,072.00
Add to cart

CABOMETYX™ tablets 40mg, 30pcs

$25,072.00
Add to cart

IRITEN™ concentrate for infusion solution 20mg/ml (5ml), vial 1pc

$195.00
Add to cart

IMBRUVICA™ capsules 140mg, 90pcs

$28,002.00
Add to cart

ZOLADEX™ implant 10.8mg, syringe applicators 1pc

$854.00
Add to cart

ZENLISTIK™ tablets 150mg, 56pcs

$4,810.00
Add to cart

ZARSIO™ solution for IV and SC injection 48 million IU/0.5ml (0.5ml), syringes 5pcs

$1,273.00
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (2ml), vial 1pc

$150.00
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (8ml), vial 1pc

$689.00
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (16ml), vial 1pc

$898.00
Add to cart

DOXORUBICIN lyophilisate for intravascular and intravesical solution 10mg, 1pc

$19.00
Add to cart

HERCEPTIN™ lyophilisate for concentrate for infusion solution 440mg + solvent 20ml, vial 1pc

$1,945.00
Add to cart

HYDREA™ capsules 500mg, 20pcs

$16.00
Add to cart

VINBLASTIN-LENS™ lyophilisate for IV infusion 5mg, vial 1pc

$27.00
Add to cart

FLUDARABINE-VERO™ lyophilisate for IV infusion 50mg, 1pc

$198.00
Add to cart

BICALUTAMIDE CANON™ tablets 50mg, 30pcs

$59.00
Add to cart

BICALUTAMIDE tablets 150mg, 30pcs

$151.00
Add to cart

BICALUTAMIDE tablets 50mg, 30pcs

$77.00
Add to cart

BARTIZAR™ lyophilisate for IV/SC injection 3.5mg, 1pc

$934.00
Add to cart

BAVENCIO™ concentrate for infusion solution 20mg/ml (10ml), vial 1pc

$3,690.00
Add to cart
Select your currency